Kukje Pharma Co., Ltd. (KRX:002720)

Kukje Pharma Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	8,678	10,590	5,539	7,866	4,013
Trading Asset Securities	76.49	42.29	20.18	36.91	260.42
Cash & Short-Term Investments	8,755	10,632	5,559	7,903	4,273
Cash Growth	-17.66%	91.26%	-29.66%	84.93%	-57.57%
Accounts Receivable	22,761	20,429	19,131	20,653	20,251
Other Receivables	741.8	708.07	1,222	2,819	3,654
Receivables	24,656	22,141	20,359	23,486	23,937
Inventory	22,369	21,243	22,235	16,540	21,652
Prepaid Expenses	28.94	35.34	35.21	23.51	27.9
Other Current Assets	1,165	1,067	347.29	244.12	49.84
Total Current Assets	56,974	55,119	48,535	48,197	49,940
Property, Plant & Equipment	98,185	99,124	78,380	81,981	86,986
Long-Term Investments	4,545	3,195	3,984	3,953	2,855
Other Intangible Assets	870.1	919.29	944.49	935.19	877.02
Long-Term Deferred Charges	0	0	180.95	398.08	615.22
Other Long-Term Assets	4,824	4,902	4,569	4,319	4,352
Total Assets	165,548	163,259	136,593	139,783	145,626
Accounts Payable	11,064	8,564	7,068	7,249	7,248
Accrued Expenses	893.87	918.01	1,235	1,110	1,110
Short-Term Debt	2,000	30,000	27,000	32,000	32,000
Current Portion of Long-Term Debt	-	-	-	2,000	2,000
Current Portion of Leases	169.69	186.34	399.95	366.36	343.72
Current Income Taxes Payable	1,372	1,566	1,488	302.48	2,489
Other Current Liabilities	13,047	18,453	10,664	11,489	10,166
Total Current Liabilities	28,547	59,687	47,855	54,517	55,358
Long-Term Debt	27,000	-	-	-	2,000
Long-Term Leases	341.94	475.74	1,196	1,620	1,792
Long-Term Deferred Tax Liabilities	12,724	13,054	7,895	7,248	7,201
Other Long-Term Liabilities	5,562	5,092	4,323	2,538	2,165
Total Liabilities	75,999	78,310	62,514	71,195	75,127
Common Stock	21,160	21,160	20,195	19,276	18,401
Additional Paid-In Capital	2,360	2,094	3,059	3,978	4,854
Retained Earnings	5,406	-3,391	6,327	1,095	3,059
Treasury Stock	-2,253	-2,566	-2,535	-2,494	-2,449
Comprehensive Income & Other	62,868	67,647	47,028	46,714	46,618
Total Common Equity	89,542	84,944	74,074	68,568	70,482
Minority Interest	6.39	5.49	5.19	19.75	16.41
Shareholders' Equity	89,548	84,950	74,079	68,588	70,499
Total Liabilities & Equity	165,548	163,259	136,593	139,783	145,626
Total Debt	29,512	30,662	28,596	35,987	38,136
Net Cash (Debt)	-20,757	-20,030	-23,037	-28,084	-33,862
Net Cash Per Share	-1020.85	-987.79	-1137.06	-1385.71	-1670.44
Filing Date Shares Outstanding	20.25	20.25	20.26	20.27	19.31
Total Common Shares Outstanding	20.25	20.25	20.26	20.27	20.27
Working Capital	28,427	-4,568	680.31	-6,319	-5,417
Book Value Per Share	4422.21	4194.43	3656.47	3383.53	3476.90
Tangible Book Value	88,672	84,025	73,130	67,633	69,605
Tangible Book Value Per Share	4379.23	4149.04	3609.85	3337.38	3433.63
Land	72,064	72,736	46,629	46,808	46,808
Buildings	25,051	25,563	26,478	26,804	26,804
Machinery	39,002	39,015	40,488	41,862	41,326
Construction In Progress	349.3	91.5	123	151.85	2,771

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.